Delivery Order SPE2DB22D2108-SPE2DB25FU5HX
- Not listed
- The Defense Logistics Agency awarded a $1,070.95 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for TUBERSOL 5T Unit/0.1 ML Vial 5ML, a tuberculosis skin test antigen used for diagnostic purposes. This non-set-aside competitive award is scheduled for completion by July 30, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $4,380.20 to AmerisourceBergen Drug Corp for Tubersol 5T Unit/0.1 ML Vial tuberculin skin test antigen. This competitively awarded, firm fixed-price delivery order was executed on August 29, 2025, with an ultimate completion date of September 2, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for $1,155.00 to supply TUBERSOL 5T UNIT/0.1 ML VIAL tuberculosis skin test antigen. The contract, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,179.04 on August 19, 2025, for the supply of Tubersol 5T Unit/0.1 mL vial 5mL tuberculin skin test antigen. This firm fixed price, non-set-aside contract is scheduled for completion by August 20, 2025, with performance at the contractor's location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,742.90 to supply Tubersol 5T Unit tuberculin skin test vials (0.1 mL, 5 mL format) with an ultimate completion date of June 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal...
- This delivery order, awarded on August 27, 2025, to AmerisourceBergen Drug Corp, provides $2,797.86 in firm fixed price pharmaceutical supplies to the Defense Logistics Agency. Specifically, the contract calls for delivery of Tubersol 5T tuberculin skin test units in 0.1 milliliter vials with 5 milliliter capacity to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with a completion date of August 28, 2025....
- This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,446.40 order is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, a pharmaceutical product, with a performance period through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor on a single award indefinite delivery contract (IDC) valued at up to $999,999,999.00 with DLA...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation, to provide TUBERSOL 5T UNIT/0.1 ML VIAL 5ML pharmaceutical products. The contract has a potential value of $1,262.58 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA through December 2025, which serves as...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, valued at $1,070.95, with a completion date of February 11, 2025. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, with a firm fixed price of $2,141.90 and an ultimate completion date of May 13, 2025. The contract is not set aside and allows for the delivery of a wide range of pharmaceutical and medical products to support military and government...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU5HXDelivery Order
The Defense Logistics Agency awarded a $2,281.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for TUBERSOL 5T Unit/0.1 ML Vial 5ML, a tuberculin skin test antigen used for tuberculosis screening. The award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-competitive delivery order placed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under the company's larger pharmaceutical supply vehicle, which supports federal medical procurement across military and veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant $999.99 billion Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX) running through December 2026, serving as a comprehensive global pharmaceutical support vehicle. This particular delivery order for tuberculin testing supplies reflects the company's role as a critical vendor supplying medications, vaccines, and medical supplies to support Defense Health Agency operations and other government healthcare systems. The non-set-aside award demonstrates AmerisourceBergen's established capability to meet federal procurement requirements and its position as a primary pharmaceutical provider within the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/5/25 |